IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities.
Mecanismos de supresión del VIH en controladores de élite excepcionales: Vinculando funciones virológicas e inmunológicas para explicar la dinámica viral
Riga Stradiņš University (Latvia); London School of Hygiene and Tropical Medicine (UK); Charité–Universitätsmedizin Berlin (Germany); Vall d'Hebron University Hospital Foundation Research Institute (Spain); Germans Trias i Pujol Institute for Health Science Research (IGTP) (Spain); Oslo University Hospital (Norway); Università Degli Studi di Pavia (Italy); Azienda Ospedaliera Mellino Mellini di Chiari (Italy); State Research Institute/Centre for Innovative Medicine (Lithuania)
The main objectives of this European network is to establish a common European research platform for myalgic encephalomyelitis and chronic fatigue syndrome (ME/CFS). The project includes standardization of biobank procedures in new and existing facilities, adaptation of bioinformatic repositories and biostatistical databases to ELIXIR and BBMRI infrastructure standards (Work Package 1) and the mapping of existing knowledge in an integrated medical model for ME/CFS (Work Package 2).
Development of therapeutic antibodies against SARS-CoV-2